Geode Capital Management
BLTE

Geode Capital Management’s Belite Bio BLTE Stock Holding History

Geode Capital Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Sell
10,427
-18
-0.2% -$3.03K ﹤0.01% 3192
2025
Q4 		$1.67M Sell
10,445
-5,180
-33% -$614K ﹤0.01% 3224
2025
Q3 		$1.16M Buy
15,625
+2,761
+21% +$181K ﹤0.01% 3341
2025
Q2 		$742K Buy
12,864
+111
+0.9% +$6.77K ﹤0.01% 3426
2025
Q1 		$845K Buy
12,753
+6,053
+90% +$365K ﹤0.01% 3360
2024
Q4 		$423K Hold
6,700
– – ﹤0.01% 3661
2024
Q3 		$314K Hold
6,700
– – ﹤0.01% 3751
2024
Q2 		$306K Hold
6,700
– – ﹤0.01% 3757
2024
Q1 		$257K Hold
6,700
– – ﹤0.01% 3856
2023
Q4 		$307K Hold
6,700
– – ﹤0.01% 3790
2023
Q3 		$212K Buy
+6,700
New +$168K ﹤0.01% 3959
2022
Q4 		– Sell
-7,264
Closed -$245K – 4901
2022
Q3 		$245K Buy
+7,264
New +$251K ﹤0.01% 4083

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management's BLTE Position: Q1 2026 in Review

Geode Capital Management reduced its Belite Bio (BLTE) stake by 0.17% in Q1 2026, selling an estimated $3.03K and leaving 10,427 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

Geode Capital Management first reported a position in BLTE in Q3 2022 and has held it in 12 quarters since. The position peaked at $1.67M in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Geode Capital Management held 10,427 shares of Belite Bio worth $1.66M as of Q1 2026.
  • Geode Capital Management sold 18 Belite Bio shares in Q1 2026, an estimated $3.03K.
  • Belite Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3192 holding.
  • Geode Capital Management first reported a position in Belite Bio in Q3 2022 and has held it in 12 quarters since.
  • Geode Capital Management's Belite Bio position peaked at $1.67M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.